Poly Medicure's Q1 FY 2025-26 Quarterly Results

Result Summary

• Poly Medicure Ltd reported a 13.2% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 10.8%.
• Its expenses for the quarter were up by 7.5% QoQ and 6.5% YoY.
• The net profit increased 36.2% QoQ and increased 25.7% YoY.
• The earnings per share (EPS) of Poly Medicure Ltd stood at 9.2 during Q1 FY 2025-26.

Financial Statments for Q1 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Poly Medicure Ltd is a prominent company in the healthcare sector, primarily involved in the manufacturing and supply of medical devices and equipment. The company is known for its extensive range of products, including infusion therapy, blood management, gastroenterology, urology, anesthesia, and surgery-related items. Poly Medicure Ltd has established a strong market presence both domestically and internationally, with a focus on quality and innovation. Recent developments for the company may include expansions in product lines or geographical reach, but specific information on recent major developments is not available within the provided data.

Revenue

In the first quarter of fiscal year 2026 (Q1FY26), Poly Medicure Ltd reported total income of ₹444.90 crores. This represents a quarter-over-quarter (QoQ) increase of 13.2% from ₹393.05 crores in the fourth quarter of fiscal year 2025 (Q4FY25), and a year-over-year (YoY) increase of 10.8% from ₹401.70 crores in the first quarter of fiscal year 2025 (Q1FY25). These figures indicate a strong revenue performance for the period under review, reflecting an upward trend in the company's income generation capabilities.

Profitability

Poly Medicure Ltd's profitability metrics for Q1FY26 reveal a positive trajectory. The company recorded a profit before tax (PBT) of ₹121.62 crores, which shows a significant QoQ growth of 31.5% from the previous quarter's ₹92.46 crores and a YoY increase of 23.5% from ₹98.46 crores in Q1FY25. After accounting for taxes, profit after tax (PAT) stood at ₹93.08 crores, up 36.2% QoQ and 25.7% YoY. The effective tax rate for the quarter appears to be consistent, with tax expenses recorded at ₹29.86 crores, indicating a 23.9% increase QoQ and 22.3% YoY. The earnings per share (EPS) was ₹9.20, marking a QoQ rise of 29.6% and a YoY improvement of 19.5%.

Operating Metrics

The operating metrics for Poly Medicure Ltd display a controlled rise in total expenses, which were ₹323.28 crores for Q1FY26. This represents a QoQ increase of 7.5% from the previous quarter's ₹300.81 crores and a YoY rise of 6.5% from ₹303.67 crores in Q1FY25. The relatively lower growth rate in expenses compared to that of total income and profitability metrics suggests efficient cost management. While specific operating ratios and metrics such as P/E ratio, debt-to-equity ratio, or current ratio are not provided in the data, the available figures denote a period of robust operational performance within the company.